As of Thursday, February 26, Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 12.27%, which has investors questioning if this is right time to sell.

In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...

A study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers at Science ...

RIKEN researchers have discovered how an enzyme modifies gene expression by targeting certain stretches of messenger RNA ...

For decades, scientists believed a fertilized egg’s DNA began as a shapeless mass, only organizing itself once the embryo switched on its genes. But new research reveals that the genome is already ...

As people age, it becomes harder to know who is on track for healthy years ahead and who may be at higher risk for serious ...

The tiny fatty capsules that delivered COVID-19 mRNA vaccines into billions of arms may work better when they're a little ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...